Ashar Bhavesh 4
4 · SpringWorks Therapeutics, Inc. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Ashar Bhavesh
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-04+75,000→ 75,000 totalExercise: $38.40Exp: 2034-01-03→ Common Stock (75,000 underlying) - Tax Payment
Common Stock
2024-01-05$37.96/sh−2,507$95,166→ 67,659 total - Tax Payment
Common Stock
2024-01-08$41.53/sh−1,449$60,177→ 66,210 total - Award
Common Stock
2024-01-04+26,445→ 70,166 total
Footnotes (3)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs and does not represent a sale by the Reporting Person.
- [F3]This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.